SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: jayhawk969 who wrote (24505)8/14/1998 4:05:00 PM
From: tonyt  Read Replies (1) | Respond to of 32384
 
LIGAND PHARMACEUTICALS INC (NASDAQ:LGND) files SEC Form 10-Q

edgar-online.com
For other Edgar reports on LIGAND PHARMACEUTICALS INC (LGND), go to:
edgar-online.com



To: jayhawk969 who wrote (24505)8/14/1998 4:28:00 PM
From: Henry Niman  Read Replies (3) | Respond to of 32384
 
Earnings show a loss of $0.45 for the quarter ($0.35 was consensus). SEC filing indicates that they have sufficient funding through 1999:

"The Company believes that its available cash, cash equivalents, marketable securities and existing sources of funding will be adequate to satisfy its anticipated capital requirements through 1999."


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News